Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Older adult US Medicare beneficiaries with untreated obstructive sleep apnea are heavier users of health care than matched control patients.

Wickwire EM, Tom SE, Vadlamani A, Diaz-Abad M, Cooper LM, Johnson AM, Scharf SM, Albrecht JS.

J Clin Sleep Med. 2020 Jan 15;16(1):81-89. doi: 10.5664/jcsm.8128. Epub 2019 Dec 5.

PMID:
31957657
2.

Cerebellar Volume Is Associated with Cognitive Decline in Mild Cognitive Impairment: Results from ADNI.

Lin CY, Chen CH, Tom SE, Kuo SH; Alzheimer’s Disease Neuroimaging Initiative.

Cerebellum. 2020 Jan 4. doi: 10.1007/s12311-019-01099-1. [Epub ahead of print]

PMID:
31900856
3.

Self-reported sleep duration is associated with time in work physical activity but not transportation or leisure physical activity among Hispanic/Latino adults in the U.S.: results from the Hispanic Community Health Study/Study of Latinos.

Tom SE, Brown JP, Avilés-Santa ML, Sotres-Alvarez D, Castañeda SF, Patel SR, Perreira K, Sanchez-Johnsen LAP, Shah NA, Zee PC, Redline S.

Sleep Health. 2019 Nov 15. pii: S2352-7218(19)30215-3. doi: 10.1016/j.sleh.2019.10.001. [Epub ahead of print]

PMID:
31740378
4.

Sex differences in Parkinson's disease presentation and progression.

Abraham DS, Gruber-Baldini AL, Magder LS, McArdle PF, Tom SE, Barr E, Schrader K, Shulman LM.

Parkinsonism Relat Disord. 2019 Dec;69:48-54. doi: 10.1016/j.parkreldis.2019.10.019. Epub 2019 Oct 23.

PMID:
31677455
5.

Economic aspects of insomnia medication treatment among Medicare beneficiaries.

Wickwire EM, Vadlamani A, Tom SE, Johnson AM, Scharf SM, Albrecht JS.

Sleep. 2020 Jan 13;43(1). pii: zsz192. doi: 10.1093/sleep/zsz192.

PMID:
31418027
6.

Impact of the Pharmacists' Patient Care Process on Medication Adherence in Older Adults With Multimorbidity.

Whittaker CF, Nelson SAW, Tom SE.

Sr Care Pharm. 2019 Jul 1;34(7):456-463. doi: 10.4140/TCP.n.2019.456..

PMID:
31383057
7.

The Impact of Treatments for OSA on Monetized Health Economic Outcomes: A Systematic Review.

Wickwire EM, Albrecht JS, Towe MM, Abariga SA, Diaz-Abad M, Shipper AG, Cooper LM, Assefa SZ, Tom SE, Scharf SM.

Chest. 2019 May;155(5):947-961. doi: 10.1016/j.chest.2019.01.009. Epub 2019 Jan 18.

8.

Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries.

Wickwire EM, Tom SE, Scharf SM, Vadlamani A, Bulatao IG, Albrecht JS.

Sleep. 2019 Apr 1;42(4). pii: zsz007. doi: 10.1093/sleep/zsz007.

9.

Trends in Insomnia Diagnosis and Treatment Among Medicare Beneficiaries, 2006-2013.

Albrecht JS, Wickwire EM, Vadlamani A, Scharf SM, Tom SE.

Am J Geriatr Psychiatry. 2019 Mar;27(3):301-309. doi: 10.1016/j.jagp.2018.10.017. Epub 2018 Nov 2.

PMID:
30503702
10.

Utilization of Screening Mammograms in the Medicare Population Before and After the Affordable Care Act Implementation.

Bozzi LM, Stuart B, Onukwugha E, Tom SE.

J Aging Health. 2020 Jan-Feb;32(1):25-32. doi: 10.1177/0898264318802047. Epub 2018 Sep 22.

PMID:
30246588
11.

Placement of selected new FDA-approved drugs in Medicare Part D formularies, 2009-2013.

Stuart BC, Tom SE, Choi M, Johnson A, Sun K, Qato D, Obi EN, Zacker C, Park Y, Arcona S.

Am J Manag Care. 2018 Jun 1;24(6):e175-e182.

12.

Comparative Effectiveness of Proton Pump Inhibitors vs Histamine Type 2 Receptor Blockers for Preventing Clinically Important Gastrointestinal Bleeding During Intensive Care: A Population-Based Study.

Lilly CM, Aljawadi M, Badawi O, Onukwugha E, Tom SE, Magder LS, Harris I.

Chest. 2018 Sep;154(3):557-566. doi: 10.1016/j.chest.2018.05.015. Epub 2018 May 30.

13.

Patterns of Early Mental Health Diagnosis and Medication Treatment in a Medicaid-Insured Birth Cohort.

Pennap D, Zito JM, Santosh PJ, Tom SE, Onukwugha E, Magder LS.

JAMA Pediatr. 2018 Jun 1;172(6):576-584. doi: 10.1001/jamapediatrics.2018.0240.

14.

Impact of formulary restrictions on medication use and costs.

Shen X, Stuart BC, Powers CA, Tom SE, Magder LS, Perfetto EM.

Am J Manag Care. 2017 Aug 1;23(8):e265-e274.

15.

Eligibility For And Enrollment In Medicare Part D Medication Therapy Management Programs Varies By Plan Sponsor.

Stuart B, Hendrick FB, Shen X, Dai M, Tom SE, Dougherty JS, Miller LM.

Health Aff (Millwood). 2016 Sep 1;35(9):1572-80. doi: 10.1377/hlthaff.2016.0258.

PMID:
27605635
16.

Examining patient-provider relationship (PPR) quality and patient activation in the Medicare population.

Mattingly TJ 2nd, Tom SE, Stuart B, Onukwugha E.

Aging Clin Exp Res. 2017 Jun;29(3):543-548. doi: 10.1007/s40520-016-0600-z. Epub 2016 Jun 20.

PMID:
27324691
17.

Nonbenzodiazepine Sedative Hypnotics and Risk of Fall-Related Injury.

Tom SE, Wickwire EM, Park Y, Albrecht JS.

Sleep. 2016 May 1;39(5):1009-14. doi: 10.5665/sleep.5742.

18.

Comparison of a simple obstructive sleep apnea screening device with standard in-laboratory polysomnography.

Assefa SZ, Diaz-Abad M, Korotinsky A, Tom SE, Scharf SM.

Sleep Breath. 2016 May;20(2):537-41. doi: 10.1007/s11325-015-1234-7. Epub 2015 Aug 12.

PMID:
26265559
19.

Health care spending and utilization by race/ethnicity under the Affordable Care Act's dependent coverage expansion.

Chen J, Bustamante AV, Tom SE.

Am J Public Health. 2015 Jul;105 Suppl 3:S499-507. doi: 10.2105/AJPH.2014.302542. Epub 2015 Apr 23.

20.

Pain management at the end of life: A comparative study of cancer, dementia, and chronic obstructive pulmonary disease patients.

Romem A, Tom SE, Beauchene M, Babington L, Scharf SM, Romem A.

Palliat Med. 2015 May;29(5):464-9. doi: 10.1177/0269216315570411. Epub 2015 Feb 13.

PMID:
25680377

Supplemental Content

Loading ...
Support Center